Mice were injected intra-peritoneally with 200 μg of anti-CD4 (OKT4; BioXcell) and/or 200 μg anti-CD8 (OKT8; BioXcell) monoclonal antibodies at days −2, −1, 0, +1, +6, and +14 relative to Raji tumor implantation. Control mice were given 200 μg mouse IgG2b and/or mouse IgG2a isotype control at same time as anti-CD4 and/or anti-CD8 treatment. Tumor growth was measured then as described above.
Anti cd4 okt4
Manufactured by BioXCell
The Anti-CD4 (OKT4) is a monoclonal antibody that binds to the CD4 receptor on T cells. It is a laboratory tool used for the identification and analysis of CD4+ T cell populations.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using anti cd4 okt4
1
Anti-CD4/CD8 Tumor Immunotherapy in Mice
2
SARS-CoV-2 Infection Kinetics in Antibody-Depleted Mice
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
BLT-L mice were administered 200 mg of anti-CD3e (OKT3) (BioxCell; cat. # BE0001–2), anti-CD4 (OKT4) (BioxCell; cat. # BE0003–2), anti-CD8 (OKT8) (BioxCell; cat. # BE0004–2), or isotype IgG2a (Thermofisher; cat # 02–6200) antibody 3-, 2-, and 1-day prior to inoculation and 4- and 8-days post inoculation with 1×106 PFU SARS-CoV-2 WA-1.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!